These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 30144)
21. Effects of H2-receptor antagonists upon physiological acid secretory states in animals. Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583 [TBL] [Abstract][Full Text] [Related]
22. Some aspects of medical management of gastrointestinal disease. I. Badley BW Can Med Assoc J; 1975 Jan; 112(2):200-4, 206. PubMed ID: 234288 [TBL] [Abstract][Full Text] [Related]
23. [Clinical trial of drugs (5): trial of drugs against diseases in the gastrointestinal canal]. Dotevall G; Walan A Lakartidningen; 1970 Jun; 67():Suppl II:79+. PubMed ID: 4920751 [No Abstract] [Full Text] [Related]
24. Inhibition of gastric secretion by anti-gastrinic and H2-blocking agents. Rovati AL Scand J Gastroenterol Suppl; 1976; 42():113-8. PubMed ID: 796963 [No Abstract] [Full Text] [Related]
25. A comparative study of the effects of prostaglandins and H2-receptor antagonists on gastric acid secretion, mucosal blood flow and ulcer formation. Banerjee AK; Christmas AJ; Hall CE Arzneimittelforschung; 1979; 29(4):634-9. PubMed ID: 39581 [TBL] [Abstract][Full Text] [Related]
26. [The role of H2 antagonists in Zollinger-Ellison syndrome]. Dammann HG; Walter TA; Müller P; Simon B Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434 [No Abstract] [Full Text] [Related]
28. [Discussions with the speakers on histamine-H2-receptor antagonists. 21 April 1978, Vienna]. Acta Med Austriaca Suppl; 1978; 10():1-11. PubMed ID: 32718 [No Abstract] [Full Text] [Related]
29. [Current views on the role of histamine and histamine H2 receptors of parietal cells in the process of gastric secretion]. Sajewicz Z Pol Tyg Lek; 1979 Jul; 34(29):1171-3. PubMed ID: 493175 [No Abstract] [Full Text] [Related]
30. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Koelz HR Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015 [TBL] [Abstract][Full Text] [Related]
31. H2-antagonists and motility of the upper gastrointestinal tract in man. Dobrilla G; de Pretis G; Comberlato M; Amplatz S Hepatogastroenterology; 1988 Feb; 35(1):30-3. PubMed ID: 2896148 [No Abstract] [Full Text] [Related]
32. [Action of metopimazine on gastric motility. Double-blind study using external digestive electromyography]. Bertrand J; Thillier JL Nouv Presse Med; 1975 Oct; 4(32):2319-20. PubMed ID: 1101213 [No Abstract] [Full Text] [Related]
36. The role of antagonists to acid secretion. Dinoso VP Compr Ther; 1982 Dec; 8(12):22-5. PubMed ID: 6130868 [No Abstract] [Full Text] [Related]
37. Role of histamine H2 receptor antagonists in nonoperative management of gastroduodenal ulcer haemorrhage. Haglund U Scand J Gastroenterol Suppl; 1987; 137():39-42. PubMed ID: 2892262 [TBL] [Abstract][Full Text] [Related]
38. Development and application of H-2 receptor antagonists. Parsons ME Scott Med J; 1977 Oct; 22(4):292-3. PubMed ID: 22125 [No Abstract] [Full Text] [Related]
39. The development of cimetidine: 1964-1976. A human story. Molinder HK J Clin Gastroenterol; 1994 Oct; 19(3):248-54. PubMed ID: 7806839 [TBL] [Abstract][Full Text] [Related]
40. A conformational approach to histamine H2-receptor antagonists. Bianucci AM; Martinelli A; Da Settimo A Farmaco Sci; 1984 Aug; 39(8):686-95. PubMed ID: 6148263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]